[Federal Register Volume 73, Number 110 (Friday, June 6, 2008)]
[Pages 32334-32335]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-12640]



Centers for Disease Control and Prevention

[60 Day-08-0740]

Proposed Data Collections Submitted for Public Comment and 

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Maryam Daneshvar, CDC

[[Page 32335]]

Reports Clearance Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 
or send an e-mail to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Medical Monitoring Project--Revision--National Center for HIV, 
Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The Medical Monitoring Project (MMP) is a nationally 
representative, population-based surveillance system to assess clinical 
outcomes, behaviors, and the quality of HIV care. The primary 
objectives of MMP are to obtain data from a national probability sample 
of HIV-infected persons receiving care in the U.S. to: (a) Describe the 
clinical status of recruited patients; (b) describe HIV care and 
support services being received and the quality of those services; (c) 
describe the prevalence and occurrence of co-morbidities related to HIV 
disease; (d) determine prevalence of ongoing risk behaviors, as well as 
the access to and use of prevention services among persons living with 
HIV; and (e) identify met and unmet needs for HIV care and prevention 
services in order to inform community and care planning groups, health 
care providers, and other stakeholders. In order to meet these 
objectives, patients will be recruited to the project from randomly 
selected HIV care providers (e.g., physicians and other care providers) 
in the U.S.
    MMP was implemented in 2005 and is currently being conducted in 26 
project areas. The methods for the project remain the same; however, 
data collection instruments have been revised based on experience in 
previous data collection cycles. An estimated 8,320 patients will 
participate in MMP each data collection cycle.
    As part of this current revision to MMP, CDC is requesting the 
addition of a survey of randomly selected HIV care providers (e.g., 
physicians, nurse practitioners and physician's assistants) in the U.S. 
regarding their training history, areas of specialization, ongoing 
sources of training and continuing education about HIV care, and 
awareness of HIV treatment guidelines and resources.
    In order to understand factors associated with access to and 
quality of care, it is necessary to understand the characteristics of 
the HIV care providers randomly selected for inclusion in the project. 
This information will be obtained by conducting a provider survey. All 
HIV care providers who are sampled into MMP--about 1440 in all--will be 
asked to participate in the survey, whether or not the provider's 
patients participate in MMP. Participation is voluntary. Those who 
consent will be asked to complete a self-administered survey which will 
include questions about training history, areas of specialization, 
ongoing sources of training and continuing education about HIV care, 
and awareness of HIV treatment guidelines and resources.
    The information collected in the MMP Provider Survey will be used 
in conjunction with other MMP data to assess who is providing HIV care, 
to examine the impact of provider characteristics on the quality and 
standard of care being provided to patients with HIV, and to determine 
opportunities to improve resources available to HIV care providers. 
There is no cost to respondents other than their time.

                                       Estimate of Annualized Burden Table
                                                                Number of      Average burden
               Respondents                    Number of       responses per     per response      Total burden
                                             respondents       respondent        (in hours)          (hours)
Patients interviewed with standard                   7,988                 1             45/60             5,991
Patients interviewed with short                        166                 1             20/60                55
Patient Proxies interviewed with proxy                 166                 1             20/60                55
Facility staff pulling medical records..             7,488                 1              3/60               374
Facility staff providing Estimated                     936                 1                 2             1,872
 Patient Loads..........................
Facility staff providing patient lists..             1,030                 1             30/60               515
Patients approached by facility staff                3,120                 1              5/60               260
 for enrollment.........................
Providers completing a survey...........             1,440                 1             20/60               480
    Total...............................  ................  ................  ................             9,602

    Dated: May 30, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
[FR Doc. E8-12640 Filed 6-5-08; 8:45 am]